N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients. (Q44357475)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12629447%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12629447%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12629447%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Wautier MP

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12629447%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Massin P

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12629447%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Guillausseau PJ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12629447%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Huijberts M

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12629447%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Levy B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12629447%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Laloi-Michelin M

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12629447%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Wautier JL

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12629447%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12629447%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

published in

Diabetes and Metabolism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12629447%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12629447%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12629447%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

44-52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12629447%20AND%20SRC:MED&resulttype=core&format=json

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Standardizing the immunological measurement of advanced glycation endproducts using normal human serum

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Negative consequences of glycation.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Biochemistry and molecular cell biology of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Diabetes, advanced glycation endproducts and vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Increased Adhesion of Erythrocytes to Endothelial Cells in Diabetes Mellitus and Its Relation to Vascular Complications

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Determination of free amino groups in proteins by trinitrobenzenesulfonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Mass spectrometric study on the protein chemical modification of uremic patients in advanced Maillard reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Antibodies to human plasma kallikrein from egg yolks of an immunized hen: preparation and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Improvements in the isolation of igy from the yolks of eggs laid by immunized hens

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Accumulation of Maillard reaction products in skin collagen in diabetes and aging

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Treatment of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Structure and mechanism of formation of human lens fluorophore LM-1. Relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021

Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970006-X

7 January 2021